Autism

The Tennessee STAT tool was associated with improved primary care provider perspective and confidence to lead, rather than refer, on pediatric autism diagnosis.

Joshua Feder, MD, explains how developmental care models for autism care can benefit children with autism, providers, parents, and other family members.

A new recommendation statement from the Preventive Services Task Force remains inconclusive on the benefits versus risks of asymptomatic screening for speech and language delay disorders.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

To determine the association between infertility and fertility treatment with ASD risk, investigators conducted a retrospective, population-based study using health data from Ontario, Canada.

Yamo Pharmaceuticals has initiated a phase 3 readiness program for L1-79, following the enrollment of its final patient in a phase 2 study evaluating the autism spectrum disorder (ASD) treatment for patients aged 2 to 21 years.

In this interview with Contemporary Pediatrics®, Lauren Lanzon, MSW, MA, BCBA, clinical trainer, Carolina Behavioral Innovations, explains how technology and software is helping families following an autism diagnosis in their child.

The 20 children in the investigation had been diagnosed with ASD by PCPs who were trained using the ECHO (Extension for Community Healthcare Outcomes) Autism Screening Tool for Autism in Toddlers and Young Children (STAT).

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The EarliPoint Evaluation has demonstrated positive phase 3 trial results, aiding in autism diagnosis and assessment in children aged 16 to 30 months. Warren Jones, PhD, chief scientific officer and cofounder of EarliTec Diagnostics, Inc., discusses the eye-tracking tool, how it is currently being used, and what could be in store for the future.

In a recent study, the prevalence of autism spectrum disorder was greater in children exposed to maternal labor epidural analgesia and oxytocin use during delivery.

A family-centered procedural sedation protocol for children with autism spectrum disorder (ASD) or developmental delay (DD) allowed 93% of patients to be free of restraints during routine health care procedures.

Reasons why primary care should incorporate the Rapid Interactive Screen Test for autism spectrum disorder were presented during a session at the 2023 Pediatric Academic Societies Meeting held in Washington, DC. 

Data pulled from 11 communities in the Autism and Developmental Disabilities (ADDM) Network demonstrate higher autism prevalence for children aged 8 years.

Both the CDC and the AAP stress the need to look at how resources are allocated for autism spectrum disorder.

In a recent study, electronic health record-based detection showed increased accuracy in early autism screening.

A systematic review and meta-analysis of nearly 3 dozen published articles details the apparent increase in risk of cardiovascular disease and diabetes associated with a diagnosis of autism.

A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.

We revisit some of last year’s top articles about autism spectrum disorder.

When comparing the rate of diagnoses for autism spectrum disorder given clinically to those given through the Autism Diagnostic Observation Schedule (ADOS), consistency between the 2 methods was found.

A new study examined the effectiveness of different survey recruitment strategies when engaging parents of children with autism.

Recent research suggests females with autism may need their own set of parameters on which to be measured.

Global prevalence of autism spectrum disorder is 1% to 2%, but little research has been done in non-White populations. An investigation offers some much-needed insight.

The US Food and Drug Administration has given marketing authorization to Cognoa, Inc. for their device to aid in the diagnosis of autism spectrum disorder (ASD).

A study examines if promoting positive behaviors including masking leads to improved face covering in children with autism spectrum disorder and/or attention-deficit/hyperactivity disorder.

Is there value in predictive testing for autism spectrum disorder (ASD)? A study examines the ethics.

The pandemic has drastically changed the lives of children, but children with autism spectrum disorder in particular lost the routines that made life easier to handle. A study presented at the virtual 2021 Pediatric Academic Societies meeting offers insight.

A recent investigation examines if people with autism spectrum disorder may be at greater risk of both death by suicide and suicide attempts.

An investigation examines whether children with autism spectrum disorder (ASD) are at increased risk of substance use disorder.

Pica can be a life-threatening condition. An investigation examines whether children with autism spectrum disorder and other developmental disorders are at greater risk of having it.